JP2016537384A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016537384A5 JP2016537384A5 JP2016533073A JP2016533073A JP2016537384A5 JP 2016537384 A5 JP2016537384 A5 JP 2016537384A5 JP 2016533073 A JP2016533073 A JP 2016533073A JP 2016533073 A JP2016533073 A JP 2016533073A JP 2016537384 A5 JP2016537384 A5 JP 2016537384A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dimethyl
- chlorophenyl
- oxo
- dihydropyrrolo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 82
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 50
- 150000001875 compounds Chemical class 0.000 claims description 36
- 150000003839 salts Chemical class 0.000 claims description 36
- -1 methoxy, cyano, methyl Chemical group 0.000 claims description 31
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 28
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 13
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 8
- 206010028980 Neoplasm Diseases 0.000 claims description 6
- 201000011510 cancer Diseases 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 4
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 4
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000004952 protein activity Effects 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 18
- HMXQIFUGFZEJEO-UHFFFAOYSA-N 1,2-dihydropyrrol-3-one Chemical compound O=C1CNC=C1 HMXQIFUGFZEJEO-UHFFFAOYSA-N 0.000 claims 4
- IWTFOFMTUOBLHG-UHFFFAOYSA-N 2-methoxypyridine Chemical compound COC1=CC=CC=N1 IWTFOFMTUOBLHG-UHFFFAOYSA-N 0.000 claims 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 claims 1
- XPDXANVGYAEATN-MRXNPFEDSA-N (6R)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1[C@@H](C=2N(C=CC2C1=O)C)C1=CC=C(C=C1)Cl XPDXANVGYAEATN-MRXNPFEDSA-N 0.000 claims 1
- QLRYSHYUZMZZPY-OAQYLSRUSA-N (6R)-6-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)[C@H]1N(C(C2=C1N(C(=C2)C=2C(=NC(=NC2)OC)OC)C)=O)C2=CN(C(C(=C2)C)=O)C QLRYSHYUZMZZPY-OAQYLSRUSA-N 0.000 claims 1
- UQMYMWRETIHSGQ-HSZRJFAPSA-N (6R)-6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-2-(2-methoxypyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)[C@H]1N(C(C2=C1N(C(=C2)C=2C(=NC=CC2)OC)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C UQMYMWRETIHSGQ-HSZRJFAPSA-N 0.000 claims 1
- SMYPWBHABVYAJK-QHCPKHFHSA-N (6S)-6-(4-chlorophenyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)[C@@H]1N(C(C2=C1N(C(=C2)C=2CCOCC2)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C SMYPWBHABVYAJK-QHCPKHFHSA-N 0.000 claims 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 claims 1
- NBJPFMDWXKYTQF-UHFFFAOYSA-N 1-(1-acetylazetidin-3-yl)-6-(4-chlorophenyl)-3-cyclopropyl-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound C(C)(=O)N1CC(C1)N1C2=C(C(=C1)C1CC1)C(N(C2C2=CC=C(C=C2)Cl)C2=CC(=C1C(=N2)N(N=N1)C)C)=O NBJPFMDWXKYTQF-UHFFFAOYSA-N 0.000 claims 1
- CASINEGODQBEAL-UHFFFAOYSA-N 1-(1-acetylazetidin-3-yl)-6-(4-chlorophenyl)-3-cyclopropyl-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound C(C)(=O)N1CC(C1)N1C2=C(C(=C1)C1CC1)C(N(C2C2=CC=C(C=C2)Cl)C=2C=C(C=1N(C2)C(=NN1)C)C)=O CASINEGODQBEAL-UHFFFAOYSA-N 0.000 claims 1
- SVEGTFMYOXJKMY-UHFFFAOYSA-N 1-(1-acetylazetidin-3-yl)-6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound C(C)(=O)N1CC(C1)N1C2=C(C(=C1)C)C(N(C2C2=CC=C(C=C2)Cl)C=2C=C(C=1N(C2)C(=NN1)C)C)=O SVEGTFMYOXJKMY-UHFFFAOYSA-N 0.000 claims 1
- UWLHKAZBBAIBEB-UHFFFAOYSA-N 1-(azetidin-3-yl)-6-(4-chlorophenyl)-3-cyclopropyl-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound N1CC(C1)N1C2=C(C(=C1)C1CC1)C(N(C2C2=CC=C(C=C2)Cl)C=2C=C(C=1N(C2)C(=NN1)C)C)=O UWLHKAZBBAIBEB-UHFFFAOYSA-N 0.000 claims 1
- IBKWVBBVOCBYKT-UHFFFAOYSA-N 1-(azetidin-3-yl)-6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-3-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound N1CC(C1)N1C2=C(C(=C1)C)C(N(C2C2=CC=C(C=C2)Cl)C2=CC(=C1C(=N2)N(N=N1)C)C)=O IBKWVBBVOCBYKT-UHFFFAOYSA-N 0.000 claims 1
- PQGBLUWWHXVVKD-UHFFFAOYSA-N 1-(azetidin-3-yl)-6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound N1CC(C1)N1C2=C(C(=C1)C)C(N(C2C2=CC=C(C=C2)Cl)C=2C=C(C=1N(C2)C(=NN1)C)C)=O PQGBLUWWHXVVKD-UHFFFAOYSA-N 0.000 claims 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 claims 1
- ZDYWXTGNQATUAC-UHFFFAOYSA-N 1-[6-(4-chlorophenyl)-5-(3,7-dimethylbenzotriazol-5-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]-3-methylurea Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(=O)NC)C)=O)C=2C=C(C1=C(N(N=N1)C)C2)C ZDYWXTGNQATUAC-UHFFFAOYSA-N 0.000 claims 1
- VDVJQFLGCFFFBP-UHFFFAOYSA-N 2,3-dihydropyrrole-1-carboxylic acid Chemical compound OC(=O)N1CCC=C1 VDVJQFLGCFFFBP-UHFFFAOYSA-N 0.000 claims 1
- OJGGGCDIKGWBSR-UHFFFAOYSA-N 2-[6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-1-yl]-N,N-dimethylacetamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)CC(=O)N(C)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C OJGGGCDIKGWBSR-UHFFFAOYSA-N 0.000 claims 1
- KGPRTZSROXHRIX-UHFFFAOYSA-N 2-[6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-1-yl]-N-methylacetamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)CC(=O)NC)=O)C=2C=C(C=1N(C2)C(=NN1)C)C KGPRTZSROXHRIX-UHFFFAOYSA-N 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- RJDVRXGILIWOCC-UHFFFAOYSA-N 3-(1-acetylazetidin-3-yl)-6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound C(C)(=O)N1CC(C1)C=1C2=C(N(C1)C)C(N(C2=O)C=2C=C(C=1N(C2)C(=NN1)C)C)C1=CC=C(C=C1)Cl RJDVRXGILIWOCC-UHFFFAOYSA-N 0.000 claims 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 claims 1
- CRYAUTCZOKUESS-UHFFFAOYSA-N 3-(azetidin-3-yl)-6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-1-methyl-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound N1CC(C1)C=1C2=C(N(C1)C)C(N(C2=O)C2=CC(=C1C(=N2)N(N=N1)C)C)C1=CC=C(C=C1)Cl CRYAUTCZOKUESS-UHFFFAOYSA-N 0.000 claims 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 claims 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims 1
- VBWJYWJSBHIBOW-UHFFFAOYSA-N 4-[5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound CN1C=C(C=C(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC=C(C#N)C=C1 VBWJYWJSBHIBOW-UHFFFAOYSA-N 0.000 claims 1
- WGVAADOVZXANRM-UHFFFAOYSA-N 4-[5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-6-yl]benzonitrile Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC=C(C#N)C=C1 WGVAADOVZXANRM-UHFFFAOYSA-N 0.000 claims 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- NHUYOZGLCLQXEB-UHFFFAOYSA-N 5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6-(4-methylphenyl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound CN1C=C(C=C(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC=C(C=C1)C NHUYOZGLCLQXEB-UHFFFAOYSA-N 0.000 claims 1
- XITXIIWQQYIONX-UHFFFAOYSA-N 5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6-phenyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound CN1C=C(C=C(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC=CC=C1 XITXIIWQQYIONX-UHFFFAOYSA-N 0.000 claims 1
- MTKZUOYFXZHUDU-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-1-methyl-6-(4-methylphenyl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC=C(C=C1)C MTKZUOYFXZHUDU-UHFFFAOYSA-N 0.000 claims 1
- SCAMMXNLCDAQKQ-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-1-methyl-6-phenyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC=CC=C1 SCAMMXNLCDAQKQ-UHFFFAOYSA-N 0.000 claims 1
- ZQXOBYVSSHZKCM-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(3-methoxyphenyl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC(=CC=C1)OC ZQXOBYVSSHZKCM-UHFFFAOYSA-N 0.000 claims 1
- ZBZCQXDDHPHITA-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-1,2-dimethyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C(=CC2C1=O)C)C)C1=CC=C(C=C1)Cl ZBZCQXDDHPHITA-UHFFFAOYSA-N 0.000 claims 1
- VAXZYGLGDOWBGT-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-1-cyclopropyl-2-(1-methyl-2-oxopyridin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C(=CC2C1=O)C=1C(N(C=CC1)C)=O)C1CC1)C1=CC=C(C=C1)Cl VAXZYGLGDOWBGT-UHFFFAOYSA-N 0.000 claims 1
- UGVSWFJGRKHVMD-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-1-cyclopropyl-2-(1-methyl-6-oxopyridin-2-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C(=CC2C1=O)C=1N(C(C=CC1)=O)C)C1CC1)C1=CC=C(C=C1)Cl UGVSWFJGRKHVMD-UHFFFAOYSA-N 0.000 claims 1
- NYYPYDLZLGCKOU-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-1-cyclopropyl-2-(1-methyl-6-oxopyridin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C(=CC2C1=O)C1=CN(C(C=C1)=O)C)C1CC1)C1=CC=C(C=C1)Cl NYYPYDLZLGCKOU-UHFFFAOYSA-N 0.000 claims 1
- XPDXANVGYAEATN-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC=C(C=C1)Cl XPDXANVGYAEATN-UHFFFAOYSA-N 0.000 claims 1
- IJUSAWCETGWNEQ-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2-methoxypyrimidin-4-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C(=CC2C1=O)C1=NC(=NC=C1)OC)C)C1=CC=C(C=C1)Cl IJUSAWCETGWNEQ-UHFFFAOYSA-N 0.000 claims 1
- WQRKDXUDKMFKPL-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-chlorophenyl)-2-(2-methoxypyrimidin-5-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C(=CC2C1=O)C=1C=NC(=NC1)OC)C)C1=CC=C(C=C1)Cl WQRKDXUDKMFKPL-UHFFFAOYSA-N 0.000 claims 1
- IXWMDWQZYYSEGS-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-fluorophenyl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC=C(C=C1)F IXWMDWQZYYSEGS-UHFFFAOYSA-N 0.000 claims 1
- LBELIXDRRWMQKV-UHFFFAOYSA-N 5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-6-(4-methoxyphenyl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC=C(C=C1)OC LBELIXDRRWMQKV-UHFFFAOYSA-N 0.000 claims 1
- DTIQMIRHDCHPIP-UHFFFAOYSA-N 6-(4-chloro-3-fluorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=C(C=C(C=C1)C1N(C(C2=C1N(C=C2)C)=O)C2=CN(C(C(=C2)C)=O)C)F DTIQMIRHDCHPIP-UHFFFAOYSA-N 0.000 claims 1
- AWTFSKPTZUHXSW-UHFFFAOYSA-N 6-(4-chloro-3-fluorophenyl)-5-(5-chloro-1-methyl-6-oxopyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC(=CN(C1=O)C)N1C(C=2N(C=CC2C1=O)C)C1=CC(=C(C=C1)Cl)F AWTFSKPTZUHXSW-UHFFFAOYSA-N 0.000 claims 1
- BRQOWLMNQSLGPU-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-cyclopropyl-5-(1,5-dimethyl-6-oxopyridin-3-yl)-2-(1-methyl-2-oxopyridin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C=2C(N(C=CC2)C)=O)C2CC2)=O)C2=CN(C(C(=C2)C)=O)C BRQOWLMNQSLGPU-UHFFFAOYSA-N 0.000 claims 1
- XSOFZNARGSJIQN-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-cyclopropyl-5-(1,5-dimethyl-6-oxopyridin-3-yl)-2-(1-methyl-6-oxopyridin-2-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C=2N(C(C=CC2)=O)C)C2CC2)=O)C2=CN(C(C(=C2)C)=O)C XSOFZNARGSJIQN-UHFFFAOYSA-N 0.000 claims 1
- SRFOIWNXIILSNJ-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-cyclopropyl-5-(1,5-dimethyl-6-oxopyridin-3-yl)-2-(1-methyl-6-oxopyridin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C2=CN(C(C=C2)=O)C)C2CC2)=O)C2=CN(C(C(=C2)C)=O)C SRFOIWNXIILSNJ-UHFFFAOYSA-N 0.000 claims 1
- JLARNLKIMMBRHR-UHFFFAOYSA-N 6-(4-chlorophenyl)-1-methyl-5-(1-methyl-6-oxopyridin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2)C)=O)C2=CN(C(C=C2)=O)C JLARNLKIMMBRHR-UHFFFAOYSA-N 0.000 claims 1
- FLASGTNYMYVYKJ-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-[2-(dimethylamino)pyrimidin-5-yl]-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C=2C=NC(=NC2)N(C)C)C)=O)C2=CN(C(C(=C2)C)=O)C FLASGTNYMYVYKJ-UHFFFAOYSA-N 0.000 claims 1
- AIPWZDCZUJGLIF-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-[6-(dimethylamino)pyridin-2-yl]-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C2=NC(=CC=C2)N(C)C)C)=O)C2=CN(C(C(=C2)C)=O)C AIPWZDCZUJGLIF-UHFFFAOYSA-N 0.000 claims 1
- LMCSAEHKLPKZOO-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-[6-(dimethylamino)pyridin-3-yl]-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C=2C=NC(=CC2)N(C)C)C)=O)C2=CN(C(C(=C2)C)=O)C LMCSAEHKLPKZOO-UHFFFAOYSA-N 0.000 claims 1
- XBQGLWPUGBREQS-UHFFFAOYSA-N 6-(4-chlorophenyl)-2-cyclopropyl-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C2CC2)C)=O)C2=CN(C(C(=C2)C)=O)C XBQGLWPUGBREQS-UHFFFAOYSA-N 0.000 claims 1
- BOMRODLYJXBVMI-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-cyclopropyl-2-(3,6-dihydro-2H-pyran-4-yl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2C2CC2)C=2CCOCC2)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C BOMRODLYJXBVMI-UHFFFAOYSA-N 0.000 claims 1
- PPCFYGSMPQKDDM-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-cyclopropyl-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C2CC2)C)=O)C2=CN(C(C(=C2)C)=O)C PPCFYGSMPQKDDM-UHFFFAOYSA-N 0.000 claims 1
- PBUQLYYLOVDBLR-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-cyclopropyl-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-1-(1-methylazetidin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C1CC1)C1CN(C1)C)=O)C1=CC(=C2C(=N1)N(N=N2)C)C PBUQLYYLOVDBLR-UHFFFAOYSA-N 0.000 claims 1
- WQTNQPWCFFMZJO-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-cyclopropyl-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-1-(hydroxymethyl)-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C2CC2)CO)=O)C2=CC(=C1C(=N2)N(N=N1)C)C WQTNQPWCFFMZJO-UHFFFAOYSA-N 0.000 claims 1
- TWYGARCNNFAUNW-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-cyclopropyl-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-1-(oxetan-3-yl)-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C2CC2)C2COC2)=O)C2=CC(=C1C(=N2)N(N=N1)C)C TWYGARCNNFAUNW-UHFFFAOYSA-N 0.000 claims 1
- KVPRUGZKNCVUEL-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-cyclopropyl-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1,2-dimethyl-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2C2CC2)C)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C KVPRUGZKNCVUEL-UHFFFAOYSA-N 0.000 claims 1
- YAJRUKJDKBVQBZ-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-cyclopropyl-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-(1-methylazetidin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C2CC2)C2CN(C2)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C YAJRUKJDKBVQBZ-UHFFFAOYSA-N 0.000 claims 1
- AVWFNEVSOVPOLY-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-cyclopropyl-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C2CC2)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C AVWFNEVSOVPOLY-UHFFFAOYSA-N 0.000 claims 1
- VQOLKEMPAJVXHY-UHFFFAOYSA-N 6-(4-chlorophenyl)-3-cyclopropyl-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-2-(2-methoxypyridin-3-yl)-1-methyl-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2C2CC2)C=2C(=NC=CC2)OC)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C VQOLKEMPAJVXHY-UHFFFAOYSA-N 0.000 claims 1
- DUZXHNLPDHPTHC-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1,2-dimethyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C)C)=O)C2=CN(C(C(=C2)C)=O)C DUZXHNLPDHPTHC-UHFFFAOYSA-N 0.000 claims 1
- LZYVFLZEQAANSW-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1,3-dimethyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C)=O)C2=CN(C(C(=C2)C)=O)C LZYVFLZEQAANSW-UHFFFAOYSA-N 0.000 claims 1
- VLEMFHFORYINCB-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-2-(1-methyl-2-oxopyridin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C=2C(N(C=CC2)C)=O)C)=O)C2=CN(C(C(=C2)C)=O)C VLEMFHFORYINCB-UHFFFAOYSA-N 0.000 claims 1
- XSISVIBLCIAEGR-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-2-(1-methyl-2-oxopyridin-4-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C2=CC(N(C=C2)C)=O)C)=O)C2=CN(C(C(=C2)C)=O)C XSISVIBLCIAEGR-UHFFFAOYSA-N 0.000 claims 1
- OYLZIDSUJMGMBF-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-2-(1-methyl-6-oxopyridin-2-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C=2N(C(C=CC2)=O)C)C)=O)C2=CN(C(C(=C2)C)=O)C OYLZIDSUJMGMBF-UHFFFAOYSA-N 0.000 claims 1
- RGKUFEQXYKVMOO-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-2-(1-methyl-6-oxopyridin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C2=CN(C(C=C2)=O)C)C)=O)C2=CN(C(C(=C2)C)=O)C RGKUFEQXYKVMOO-UHFFFAOYSA-N 0.000 claims 1
- MSZSAGAHXQKHRZ-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-2-[2-(trifluoromethyl)pyrimidin-4-yl]-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C2=NC(=NC=C2)C(F)(F)F)C)=O)C2=CN(C(C(=C2)C)=O)C MSZSAGAHXQKHRZ-UHFFFAOYSA-N 0.000 claims 1
- LWGUCDPMTIPABX-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-2-pyridin-2-yl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C2=NC=CC=C2)C)=O)C2=CN(C(C(=C2)C)=O)C LWGUCDPMTIPABX-UHFFFAOYSA-N 0.000 claims 1
- QNRNHBQTJGHZSO-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2)C)=O)C2=CN(C(C(=C2)C)=O)C QNRNHBQTJGHZSO-UHFFFAOYSA-N 0.000 claims 1
- WQEGQSRMXSLEON-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-2-(2-methoxypyrimidin-5-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C=2C=NC(=NC2)OC)C)=O)C2=CN(C(C(=C2)C)=O)C WQEGQSRMXSLEON-UHFFFAOYSA-N 0.000 claims 1
- GWHBOLQUVHIAPZ-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-2-(6-methoxypyridin-2-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C2=NC(=CC=C2)OC)C)=O)C2=CN(C(C(=C2)C)=O)C GWHBOLQUVHIAPZ-UHFFFAOYSA-N 0.000 claims 1
- IMBCMESWDHPIDA-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(1,5-dimethyl-6-oxopyridin-3-yl)-2-(6-methoxypyridin-3-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C=2C=NC(=CC2)OC)C)=O)C2=CN(C(C(=C2)C)=O)C IMBCMESWDHPIDA-UHFFFAOYSA-N 0.000 claims 1
- CSMGGKQPASRAIQ-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,7-dimethylbenzotriazol-5-yl)-1,3-dimethyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C)=O)C=2C=C(C1=C(N(N=N1)C)C2)C CSMGGKQPASRAIQ-UHFFFAOYSA-N 0.000 claims 1
- VQZKOWOEYPJMPU-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,7-dimethylbenzotriazol-5-yl)-N,1-dimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-3-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C(=O)NC)C)=O)C=2C=C(C1=C(N(N=N1)C)C2)C VQZKOWOEYPJMPU-UHFFFAOYSA-N 0.000 claims 1
- YINBDXKXEYUKBO-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-1,3-dimethyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C)=O)C2=CC(=C1C(=N2)N(N=N1)C)C YINBDXKXEYUKBO-UHFFFAOYSA-N 0.000 claims 1
- ZLVIFBCNFIAMBN-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-1-(methoxymethyl)-3-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)COC)=O)C2=CC(=C1C(=N2)N(N=N1)C)C ZLVIFBCNFIAMBN-UHFFFAOYSA-N 0.000 claims 1
- CHBGVONAUISDSX-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-3-methyl-1-(1-methylazetidin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C2CN(C2)C)=O)C2=CC(=C1C(=N2)N(N=N1)C)C CHBGVONAUISDSX-UHFFFAOYSA-N 0.000 claims 1
- DDRRENHDNHGPEG-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-N,1-dimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-3-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C(=O)NC)C)=O)C2=CC(=C1C(=N2)N(N=N1)C)C DDRRENHDNHGPEG-UHFFFAOYSA-N 0.000 claims 1
- IPYPJQJYDYFZCL-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-N,N,1-trimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-3-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C(=O)N(C)C)C)=O)C2=CC(=C1C(=N2)N(N=N1)C)C IPYPJQJYDYFZCL-UHFFFAOYSA-N 0.000 claims 1
- FRDRCUWLVRNFIJ-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1,3-dimethyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C FRDRCUWLVRNFIJ-UHFFFAOYSA-N 0.000 claims 1
- MBXHXEWZLTYTML-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1,6-dihydropyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1NC=C2)=O)C=2C=C(C=1N(C2)C(=NN1)C)C MBXHXEWZLTYTML-UHFFFAOYSA-N 0.000 claims 1
- HMXDNEFPCAGWPH-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-[1-(2-methoxyacetyl)azetidin-3-yl]-3-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C2CN(C2)C(COC)=O)=O)C=2C=C(C=1N(C2)C(=NN1)C)C HMXDNEFPCAGWPH-UHFFFAOYSA-N 0.000 claims 1
- HXGQYSSCVKIEIA-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-2-(oxan-4-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2)C2CCOCC2)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C HXGQYSSCVKIEIA-UHFFFAOYSA-N 0.000 claims 1
- OCOWZEOSBFUWRU-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-3-(1-methylazetidin-3-yl)-6H-pyrrolo[2,3-c]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C2CN(C2)C)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C OCOWZEOSBFUWRU-UHFFFAOYSA-N 0.000 claims 1
- NVRXYLMWFKVLJI-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-3-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C(=O)N)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C NVRXYLMWFKVLJI-UHFFFAOYSA-N 0.000 claims 1
- YOJSJEQVJUYKIK-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C YOJSJEQVJUYKIK-UHFFFAOYSA-N 0.000 claims 1
- OMLHQPIYXLWGGG-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-2-(1-methyl-2-oxopyridin-3-yl)-1,6-dihydropyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1NC(=C2)C=2C(N(C=CC2)C)=O)=O)C=2C=C(C=1N(C2)C(=NN1)C)C OMLHQPIYXLWGGG-UHFFFAOYSA-N 0.000 claims 1
- MJTVRIBROYBHIV-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-2-(2-oxo-1H-pyridin-3-yl)-1,6-dihydropyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1NC(=C2)C=2C(=NC=CC2)O)=O)C=2C=C(C=1N(C2)C(=NN1)C)C MJTVRIBROYBHIV-UHFFFAOYSA-N 0.000 claims 1
- JMENTVKUBOUMCJ-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-1,6-dihydropyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1NC=C2C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C JMENTVKUBOUMCJ-UHFFFAOYSA-N 0.000 claims 1
- WEWCBQWPGVKVPY-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-1-(1-methyl-2-oxopyrrolidin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C2C(N(CC2)C)=O)=O)C=2C=C(C=1N(C2)C(=NN1)C)C WEWCBQWPGVKVPY-UHFFFAOYSA-N 0.000 claims 1
- DVICYEUYFBDIJO-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-1-(1-methylazetidin-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C2CN(C2)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C DVICYEUYFBDIJO-UHFFFAOYSA-N 0.000 claims 1
- PKHUSSXCMLLVRI-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-1-(oxetan-3-yl)-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C2COC2)=O)C=2C=C(C=1N(C2)C(=NN1)C)C PKHUSSXCMLLVRI-UHFFFAOYSA-N 0.000 claims 1
- TUXHCXODKHDHKT-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-N,1-dimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-3-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C(=O)NC)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C TUXHCXODKHDHKT-UHFFFAOYSA-N 0.000 claims 1
- NRKGWEXMFVBBBE-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-N,3-dimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-1-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C(=O)NC)=O)C=2C=C(C=1N(C2)C(=NN1)C)C NRKGWEXMFVBBBE-UHFFFAOYSA-N 0.000 claims 1
- JKTAXQJDSRMHSS-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-N,N,1-trimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-3-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C(=O)N(C)C)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C JKTAXQJDSRMHSS-UHFFFAOYSA-N 0.000 claims 1
- QXTHZAMLLIIJHM-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-N,N,3-trimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-1-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C(=O)N(C)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C QXTHZAMLLIIJHM-UHFFFAOYSA-N 0.000 claims 1
- IITSESCLMNYTBQ-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-N,N-dimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-1-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2)C(=O)N(C)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C IITSESCLMNYTBQ-UHFFFAOYSA-N 0.000 claims 1
- BTGFLXGQPNRXDH-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-N-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-1-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2)C(=O)NC)=O)C=2C=C(C=1N(C2)C(=NN1)C)C BTGFLXGQPNRXDH-UHFFFAOYSA-N 0.000 claims 1
- CURNKPOFSHNCQW-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-1-methyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2)C)=O)C=2C=C(C=1N(N2)C(=NN1)C)C CURNKPOFSHNCQW-UHFFFAOYSA-N 0.000 claims 1
- IAYAEBUJIVBSPF-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-[3-(difluoromethyl)-8-methyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl]-1,3-dimethyl-6H-pyrrolo[3,4-b]pyrrol-4-one Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C)=O)C=2C=C(C=1N(C2)C(=NN1)C(F)F)C IAYAEBUJIVBSPF-UHFFFAOYSA-N 0.000 claims 1
- LDQWWSKUZGJSPQ-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-[3-(difluoromethyl)-8-methyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl]-N,1-dimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-3-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C(=O)NC)C)=O)C=2C=C(C=1N(C2)C(=NN1)C(F)F)C LDQWWSKUZGJSPQ-UHFFFAOYSA-N 0.000 claims 1
- CYZNNGBIFDNKBV-UHFFFAOYSA-N 6-(4-chlorophenyl)-5-[3-(difluoromethyl)-8-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-N,1-dimethyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-3-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C(=O)NC)C)=O)C=2C=C(C=1N(N2)C(=NN1)C(F)F)C CYZNNGBIFDNKBV-UHFFFAOYSA-N 0.000 claims 1
- WSQOJBUQSYKMGG-UHFFFAOYSA-N 6-(4-chlorophenyl)-N-[2-(dimethylamino)ethyl]-5-(3,7-dimethylbenzotriazol-5-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-3-carboxamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C(=O)NCCN(C)C)C)=O)C=2C=C(C1=C(N(N=N1)C)C2)C WSQOJBUQSYKMGG-UHFFFAOYSA-N 0.000 claims 1
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 claims 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 claims 1
- SSELZXGQLGXCDT-HXUWFJFHSA-N N-[(6R)-6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]acetamide Chemical compound ClC1=CC=C(C=C1)[C@H]1N(C(C2=C1N(C=C2NC(C)=O)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C SSELZXGQLGXCDT-HXUWFJFHSA-N 0.000 claims 1
- KGAKOIGDOIZZOQ-UHFFFAOYSA-N N-[6-(4-chlorophenyl)-5-(3,7-dimethylbenzotriazol-5-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]-3-(dimethylamino)propanamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(CCN(C)C)=O)C)=O)C=2C=C(C1=C(N(N=N1)C)C2)C KGAKOIGDOIZZOQ-UHFFFAOYSA-N 0.000 claims 1
- LZQJKADDYCLNSB-UHFFFAOYSA-N N-[6-(4-chlorophenyl)-5-(3,7-dimethylbenzotriazol-5-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]acetamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(C)=O)C)=O)C=2C=C(C1=C(N(N=N1)C)C2)C LZQJKADDYCLNSB-UHFFFAOYSA-N 0.000 claims 1
- DGXUFGAFFVEFEU-UHFFFAOYSA-N N-[6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]acetamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(C)=O)C)=O)C2=CC(=C1C(=N2)N(N=N1)C)C DGXUFGAFFVEFEU-UHFFFAOYSA-N 0.000 claims 1
- CRXLFEZLSZPQMT-UHFFFAOYSA-N N-[6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]-2-(dimethylamino)acetamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(CN(C)C)=O)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C CRXLFEZLSZPQMT-UHFFFAOYSA-N 0.000 claims 1
- SSELZXGQLGXCDT-UHFFFAOYSA-N N-[6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]acetamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(C)=O)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C SSELZXGQLGXCDT-UHFFFAOYSA-N 0.000 claims 1
- FESHYOISGIZOBW-UHFFFAOYSA-N N-[6-(4-chlorophenyl)-5-[3-(difluoromethyl)-8-methyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl]-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]-2-(dimethylamino)acetamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(CN(C)C)=O)C)=O)C=2C=C(C=1N(C2)C(=NN1)C(F)F)C FESHYOISGIZOBW-UHFFFAOYSA-N 0.000 claims 1
- UCOMAESNVXJEIJ-UHFFFAOYSA-N N-[6-(4-chlorophenyl)-5-[3-(difluoromethyl)-8-methyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl]-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]acetamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(C)=O)C)=O)C=2C=C(C=1N(C2)C(=NN1)C(F)F)C UCOMAESNVXJEIJ-UHFFFAOYSA-N 0.000 claims 1
- XYESNEVBCXKVML-UHFFFAOYSA-N N-[6-(4-chlorophenyl)-5-[3-(difluoromethyl)-8-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]-3-(dimethylamino)propanamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(CCN(C)C)=O)C)=O)C=2C=C(C=1N(N2)C(=NN1)C(F)F)C XYESNEVBCXKVML-UHFFFAOYSA-N 0.000 claims 1
- KDVBPVJMVKBRPB-UHFFFAOYSA-N N-[6-(4-chlorophenyl)-5-[3-(difluoromethyl)-8-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]acetamide Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(C)=O)C)=O)C=2C=C(C=1N(N2)C(=NN1)C(F)F)C KDVBPVJMVKBRPB-UHFFFAOYSA-N 0.000 claims 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- WEHPZXXDBNJUIG-UHFFFAOYSA-N ethyl 3-[6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-1-yl]azetidine-1-carboxylate Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C2CN(C2)C(=O)OCC)=O)C=2C=C(C=1N(C2)C(=NN1)C)C WEHPZXXDBNJUIG-UHFFFAOYSA-N 0.000 claims 1
- XQCLLKJYKDIUDW-UHFFFAOYSA-N ethyl 6-(4-chlorophenyl)-2-(3,6-dihydro-2H-pyran-4-yl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-1-carboxylate Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2C)C=2CCOCC2)C(=O)OCC)=O)C=2C=C(C=1N(C2)C(=NN1)C)C XQCLLKJYKDIUDW-UHFFFAOYSA-N 0.000 claims 1
- FZOWBAIZBAZQAF-UHFFFAOYSA-N ethyl 6-(4-chlorophenyl)-3-cyclopropyl-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-4-oxo-6H-pyrrolo[2,3-c]pyrrole-1-carboxylate Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C2CC2)C(=O)OCC)=O)C=2C=C(C=1N(C2)C(=NN1)C)C FZOWBAIZBAZQAF-UHFFFAOYSA-N 0.000 claims 1
- VBNIZIAZOQSIGW-UHFFFAOYSA-N ethyl 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-2-(2-methoxypyridin-3-yl)-3-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-1-carboxylate Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C(=C2C)C=2C(=NC=CC2)OC)C(=O)OCC)=O)C=2C=C(C=1N(C2)C(=NN1)C)C VBNIZIAZOQSIGW-UHFFFAOYSA-N 0.000 claims 1
- JVTTVFOTQZIFEV-UHFFFAOYSA-N ethyl 6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrole-1-carboxylate Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2C)C(=O)OCC)=O)C=2C=C(C=1N(C2)C(=NN1)C)C JVTTVFOTQZIFEV-UHFFFAOYSA-N 0.000 claims 1
- ZSHUBSUFZWWFGQ-UHFFFAOYSA-N ethyl N-[6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]carbamate Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(OCC)=O)C)=O)C2=CC(=C1C(=N2)N(N=N1)C)C ZSHUBSUFZWWFGQ-UHFFFAOYSA-N 0.000 claims 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 claims 1
- KDRSWORUPZEOGX-UHFFFAOYSA-N tert-butyl N-[6-(4-chlorophenyl)-5-(3,7-dimethyltriazolo[4,5-b]pyridin-5-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]carbamate Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(OC(C)(C)C)=O)C)=O)C2=CC(=C1C(=N2)N(N=N1)C)C KDRSWORUPZEOGX-UHFFFAOYSA-N 0.000 claims 1
- QWMJOPLEXJAKPN-UHFFFAOYSA-N tert-butyl N-[6-(4-chlorophenyl)-5-(3,8-dimethyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1-methyl-4-oxo-6H-pyrrolo[3,4-b]pyrrol-3-yl]carbamate Chemical compound ClC1=CC=C(C=C1)C1N(C(C2=C1N(C=C2NC(OC(C)(C)C)=O)C)=O)C=2C=C(C=1N(C2)C(=NN1)C)C QWMJOPLEXJAKPN-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 description 3
- 239000013543 active substance Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13193825 | 2013-11-21 | ||
| EP13193825.0 | 2013-11-21 | ||
| PCT/IB2014/066199 WO2015075665A1 (en) | 2013-11-21 | 2014-11-20 | Pyrrolopyrrolone derivatives and their use as bet inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016537384A JP2016537384A (ja) | 2016-12-01 |
| JP2016537384A5 true JP2016537384A5 (enExample) | 2017-12-21 |
Family
ID=49596200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533073A Pending JP2016537384A (ja) | 2013-11-21 | 2014-11-20 | ピロロピロロン誘導体およびｂｅｔ阻害剤としてのその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9550796B2 (enExample) |
| EP (1) | EP3071571A1 (enExample) |
| JP (1) | JP2016537384A (enExample) |
| KR (1) | KR20160086930A (enExample) |
| CN (1) | CN105916857B (enExample) |
| AU (1) | AU2014351413B2 (enExample) |
| CA (1) | CA2931249A1 (enExample) |
| EA (1) | EA029269B1 (enExample) |
| MX (1) | MX2016006667A (enExample) |
| WO (1) | WO2015075665A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2019117356A (ru) | 2016-11-10 | 2020-12-10 | Лосинь Фармасьютикал (Шанхай) Ко., Лтд. | Азотсодержащее макроциклическое соединение, способ его получения, фармацевтическая композиция и применение |
| JP2021008407A (ja) * | 2017-10-02 | 2021-01-28 | 武田薬品工業株式会社 | 複素環化合物 |
| KR20210138585A (ko) * | 2019-03-15 | 2021-11-19 | 닛뽕소다 가부시키가이샤 | 복소 고리 화합물 및 농원예용 살균제 |
| CN114502534A (zh) | 2019-09-30 | 2022-05-13 | 协和麒麟株式会社 | Bet降解剂 |
| KR20260019479A (ko) | 2023-05-04 | 2026-02-10 | 레볼루션 메디슨즈, 인크. | Ras 관련 질환 또는 장애를 위한 병용 요법 |
| CN121889155A (zh) | 2023-08-07 | 2026-04-17 | 锐新医药公司 | 用于治疗ras蛋白相关疾病或病症的rmc-6291 |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| US20250375445A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
| WO2026090116A2 (en) | 2024-10-21 | 2026-04-30 | Revolution Medicines, Inc. | Ras inhibitors |
| US20260108528A1 (en) | 2024-10-22 | 2026-04-23 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2026090245A1 (en) | 2024-10-22 | 2026-04-30 | Revolution Medicines, Inc. | Use of ras inhibitors for treating cancer |
| WO2026106912A1 (en) | 2024-11-12 | 2026-05-21 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026112260A1 (en) | 2024-11-21 | 2026-05-28 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026122764A2 (en) | 2024-12-06 | 2026-06-11 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026128688A2 (en) | 2024-12-13 | 2026-06-18 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026161839A1 (en) | 2025-01-27 | 2026-07-30 | Revolution Medicines, Inc. | Ras inhibitors |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3829420A (en) | 1970-07-13 | 1974-08-13 | Sumitomo Chemical Co | 3,4-dihydro-2(1h)-quinazolinones and preparation thereof |
| US4099002A (en) | 1970-12-23 | 1978-07-04 | Sumitomo Chemical Company, Limited | Quinazolinone derivatives and a process for production thereof |
| JPS4822715B1 (enExample) | 1970-12-28 | 1973-07-07 | ||
| JPS5427356B2 (enExample) | 1972-03-31 | 1979-09-10 | ||
| US4258187A (en) | 1977-06-16 | 1981-03-24 | E. I. Du Pont De Nemours And Company | Process for preparing quinazolinone oxides |
| US4335127A (en) | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| JPS5721388A (en) | 1980-07-11 | 1982-02-04 | Nippon Nohyaku Co Ltd | Condensed pyrazole derivative |
| DE3420799A1 (de) | 1984-06-04 | 1985-12-05 | Bayer Ag, 5090 Leverkusen | Chromogene 4,4-diaryl-dihydrochinazolone, ihre herstellung und verwendung |
| WO1993004047A1 (en) | 1991-08-16 | 1993-03-04 | Merck & Co., Inc. | Quinazoline derivatives as inhibitors of hiv reverse transcriptase |
| US5508300A (en) | 1994-01-14 | 1996-04-16 | Pfizer Inc. | Dihydro pyrazolopyrroles, compositions and use |
| EP0958305B1 (en) | 1996-07-05 | 2008-06-04 | Cancer Research Technology Limited | Inhibitions of the interaction between p53 and mdm2 |
| HRP980143A2 (en) | 1997-04-09 | 1999-02-28 | Soo Sung Ko | 4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
| WO2000066560A1 (en) | 1999-05-04 | 2000-11-09 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| JP2001302515A (ja) | 2000-04-18 | 2001-10-31 | Sumitomo Pharmaceut Co Ltd | ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤 |
| US6479499B1 (en) | 2000-06-28 | 2002-11-12 | National Science Council | 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions |
| CA2416527C (en) | 2000-08-10 | 2009-12-22 | Pharmacia Italia S.P.A. | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| KR100650966B1 (ko) | 2001-12-18 | 2006-11-30 | 에프. 호프만-라 로슈 아게 | 시스-2,4,5-트리페닐-이미다졸린 및 종양 치료에서의 그의용도 |
| CA2473740A1 (en) | 2002-01-18 | 2003-07-31 | David Solow-Cordero | Methods of treating conditions associated with an edg receptor |
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| US20060189511A1 (en) | 2002-05-13 | 2006-08-24 | Koblish Holly K | Method for cytoprotection through mdm2 and hdm2 inhibition |
| US7119111B2 (en) | 2002-05-29 | 2006-10-10 | Amgen, Inc. | 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| AU2003253165A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
| US20040214856A1 (en) | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
| US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
| US20040213264A1 (en) | 2003-04-25 | 2004-10-28 | Nortel Networks Limited | Service class and destination dominance traffic management |
| WO2005019188A1 (ja) | 2003-08-22 | 2005-03-03 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
| AU2004273610B2 (en) | 2003-09-22 | 2010-07-01 | Onepharm Research & Development Gmbh | Prevention and treatment of inflammation-induced and/or immune-mediated bone loss |
| SI1689724T1 (sl) | 2003-11-25 | 2012-04-30 | Novartis Ag | Spojine kinazolinona kot sredstva proti raku |
| KR20080027969A (ko) | 2004-05-18 | 2008-03-28 | 에프. 호프만-라 로슈 아게 | 신규 ｃｉｓ-이미다졸린 |
| WO2005117876A1 (en) | 2004-06-01 | 2005-12-15 | University Of Virginia Patent Foundation | Dual small molecule inhibitors of cancer and angiogenesis |
| GB0419481D0 (en) | 2004-09-02 | 2004-10-06 | Cancer Rec Tech Ltd | Isoindolin-1-one derivatives |
| US20060069085A1 (en) | 2004-09-28 | 2006-03-30 | Rulin Zhao | Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| WO2006074262A1 (en) | 2005-01-05 | 2006-07-13 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| EP1868685A2 (en) | 2005-03-18 | 2007-12-26 | onepharm GmbH | 11ß-HYDROXYSTEROID DEHYDROGENASES |
| AR056285A1 (es) | 2005-03-23 | 2007-10-03 | Syngenta Participations Ag | Derivados de triazolopirimidina y composiciones fungicidas |
| US7576082B2 (en) | 2005-06-24 | 2009-08-18 | Hoffman-La Roche Inc. | Oxindole derivatives |
| WO2007068637A1 (en) | 2005-12-12 | 2007-06-21 | Nerviano Medical Sciences S.R.L. | Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors |
| WO2007096334A1 (en) * | 2006-02-24 | 2007-08-30 | Pfizer Italia Srl | Pyrrolopyrrolones active as kinase inhibitors |
| DE102006016426A1 (de) | 2006-04-07 | 2007-10-11 | Merck Patent Gmbh | Neuartige Cyclobutyl-Verbindungen als Kinase-Inhibitoren |
| WO2007144384A1 (en) | 2006-06-14 | 2007-12-21 | 4Sc Ag | Pyrazolopyrimidones |
| US8222288B2 (en) | 2006-08-30 | 2012-07-17 | The Regents Of The University Of Michigan | Small molecule inhibitors of MDM2 and the uses thereof |
| WO2008034039A2 (en) | 2006-09-15 | 2008-03-20 | Nexuspharma Inc. | Novel tetrahydro-isoquinolines |
| WO2008045529A1 (en) | 2006-10-12 | 2008-04-17 | Serenex, Inc. | Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| TW200843739A (en) | 2007-03-30 | 2008-11-16 | Shionogi & Co | Novel pyrrolinone derivative and composition containing the same |
| WO2008130614A2 (en) | 2007-04-20 | 2008-10-30 | University Of Pittsburg-Of The Commonwealth System Of Higher Education | Selective and dual-action p53/mdm2/mdm4 antagonists |
| AU2008345225A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| UY31982A (es) | 2008-07-16 | 2010-02-26 | Boehringer Ingelheim Int | Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas |
| JP5637562B2 (ja) | 2008-09-25 | 2014-12-10 | 塩野義製薬株式会社 | 新規ピロリノン誘導体およびそれを含有する医薬組成物 |
| WO2010047956A1 (en) | 2008-10-08 | 2010-04-29 | Bristol-Myers Squibb Company | Azolopyrrolone melanin concentrating hormone receptor-1 antagonists |
| RU2016116516A (ru) | 2008-12-08 | 2018-12-07 | Мандифарма Интернэшнл Корпорейшн Лимитед | Композиции ингибиторов тирозинкиназных рецепторов белков |
| WO2010141738A2 (en) | 2009-06-03 | 2010-12-09 | President And Fellows Of Harvard College | Compositions and method for inhibiting tumor growth |
| US8440693B2 (en) | 2009-12-22 | 2013-05-14 | Novartis Ag | Substituted isoquinolinones and quinazolinones |
| EP2585465B1 (en) | 2010-06-22 | 2014-11-12 | GlaxoSmithKline LLC | Benzotriazolodiazepine compounds inhibitors of bromodomains |
| US20120065210A1 (en) | 2010-09-15 | 2012-03-15 | Xin-Jie Chu | Substituted hexahydropyrrolo[1,2-c]imidazolones |
| GB201016880D0 (en) | 2010-10-07 | 2010-11-17 | Riotech Pharmaceuticals Ltd | Phosphodiesterase inhibitors |
| PE20140408A1 (es) | 2010-11-12 | 2014-04-10 | Univ Michigan | Derivados espiro-oxindol como antagonistas de mdm2 |
| SI2640467T1 (sl) | 2010-11-19 | 2015-04-30 | Novartis Ag | Kristalinična oblika inhibitorja interakcije MDM2/4 in P53 |
| WO2012151512A2 (en) | 2011-05-04 | 2012-11-08 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| WO2012174487A2 (en) * | 2011-06-17 | 2012-12-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| EP2721007B1 (en) | 2011-06-20 | 2015-04-29 | Novartis AG | Cyclohexyl isoquinolinone compounds |
| EP2721008B1 (en) | 2011-06-20 | 2015-04-29 | Novartis AG | Hydroxy substituted isoquinolinone derivatives as p53 (mdm2 or mdm4) inhibitors |
| WO2013027168A1 (en) | 2011-08-22 | 2013-02-28 | Pfizer Inc. | Novel heterocyclic compounds as bromodomain inhibitors |
| WO2013033268A2 (en) | 2011-08-29 | 2013-03-07 | Coferon, Inc. | Bivalent bromodomain ligands, and methods of using same |
| WO2013080141A1 (en) * | 2011-11-29 | 2013-06-06 | Novartis Ag | Pyrazolopyrrolidine compounds |
| WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| UY34591A (es) | 2012-01-26 | 2013-09-02 | Novartis Ag | Compuestos de imidazopirrolidinona |
| US20130281399A1 (en) | 2012-04-19 | 2013-10-24 | Rvx Therapeutics Inc. | Treatment of diseases by epigenetic regulation |
| US20130281396A1 (en) | 2012-04-19 | 2013-10-24 | Rvx Therapeutics Inc. | Treatment of diseases by epigenetic regulation |
| US20130281397A1 (en) | 2012-04-19 | 2013-10-24 | Rvx Therapeutics Inc. | Treatment of diseases by epigenetic regulation |
| WO2013155695A1 (en) | 2012-04-20 | 2013-10-24 | Abbott Laboratories | Isoindolone derivatives |
| EP2855483B1 (en) | 2012-05-24 | 2017-10-25 | Novartis AG | Pyrrolopyrrolidinone compounds |
| CN105209467B (zh) * | 2013-05-27 | 2018-06-08 | 诺华股份有限公司 | 咪唑并吡咯烷酮衍生物及其在治疗疾病中的用途 |
-
2014
- 2014-11-20 MX MX2016006667A patent/MX2016006667A/es unknown
- 2014-11-20 KR KR1020167016075A patent/KR20160086930A/ko not_active Withdrawn
- 2014-11-20 JP JP2016533073A patent/JP2016537384A/ja active Pending
- 2014-11-20 CN CN201480073531.1A patent/CN105916857B/zh not_active Expired - Fee Related
- 2014-11-20 AU AU2014351413A patent/AU2014351413B2/en not_active Ceased
- 2014-11-20 EA EA201691058A patent/EA029269B1/ru not_active IP Right Cessation
- 2014-11-20 US US15/037,116 patent/US9550796B2/en not_active Expired - Fee Related
- 2014-11-20 EP EP14812645.1A patent/EP3071571A1/en not_active Withdrawn
- 2014-11-20 WO PCT/IB2014/066199 patent/WO2015075665A1/en not_active Ceased
- 2014-11-20 CA CA2931249A patent/CA2931249A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022184886A5 (enExample) | ||
| JP7654071B2 (ja) | 複素環スピロ化合物及び使用方法 | |
| RU2424242C2 (ru) | Азолопиримидины в качестве ингибиторов активности каннабиноидного рецептора 1 | |
| JP2018529731A5 (enExample) | ||
| JP2016520116A5 (enExample) | ||
| JP7860103B2 (ja) | 複素環式スピロ化合物及びその使用方法 | |
| RU2473549C2 (ru) | Пиримидиновые соединения, композиции и способы применения | |
| JP2019535664A5 (enExample) | ||
| JP2020504136A5 (enExample) | ||
| RU2019115115A (ru) | Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7 | |
| JP2021528467A5 (enExample) | ||
| JP2022500402A5 (enExample) | ||
| RU2019120986A (ru) | Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2 | |
| RU2016140338A (ru) | Азаспиро производные в качестве антагонистов trpm8 | |
| JP2016520118A5 (enExample) | ||
| JP2012515786A5 (enExample) | ||
| RU2018123779A (ru) | Новые соединения | |
| JP2016529292A5 (enExample) | ||
| SI3083625T1 (en) | Pyrimidopyrimidinones, useful as Wee-1 kinase inhibitors | |
| JP2015517566A5 (enExample) | ||
| HRP20120105T1 (hr) | Aminoheterociklički spojevi | |
| JP2015508075A5 (enExample) | ||
| RU2017121278A (ru) | Триазоло-пиразинильные производные, применимые в качестве растворимых активаторов гуанилатциклазы | |
| JP2003531210A5 (enExample) | ||
| HRP20200342T1 (hr) | Derivati dihidroimidazopirazinona korisni u liječenju raka |